Amphastar Pharmaceuticals, Inc. (AMPH) vs Harrow, Inc. (HROW)

Amphastar Pharmaceuticals, Inc. and Harrow, Inc. are both Drug Manufacturers Specialty & Generic companies. Harrow, Inc. is the larger, with a market value of $1.2B against $1.1B — 1.1× the size. Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Amphastar Pharmaceuticals, Inc. trades at 15.0×. Harrow, Inc. grew revenue faster over the last twelve months: 21.1% against 1.02%. Amphastar Pharmaceuticals, Inc. has the higher net margin (10.8% vs −13.5%) and the higher return on invested capital (6.57% vs −0.77%). Across the 20 metrics below, Amphastar Pharmaceuticals, Inc. leads on 16 and Harrow, Inc. on 4.